<VariationArchive VariationID="4412" VariationName="NM_020919.4(ALS2):c.4721del (p.Val1574fs)" VariationType="Deletion" Accession="VCV000004412" Version="4" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-29" DateCreated="2013-05-03" MostRecentSubmission="2020-02-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="19451" VariationID="4412">
      <GeneList>
        <Gene Symbol="ALS2" FullName="alsin Rho guanine nucleotide exchange factor ALS2" GeneID="57679" HGNC_ID="HGNC:443" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q33.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="201700267" stop="201780933" display_start="201700267" display_stop="201780933" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="202564985" stop="202645894" display_start="202564985" display_stop="202645894" Strand="-" />
          </Location>
          <OMIM>606352</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_020919.4(ALS2):c.4721del (p.Val1574fs)</Name>
      <CanonicalSPDI>NC_000002.12:201704570:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q33.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="201704571" stop="201704571" display_start="201704571" display_stop="201704571" variantLength="1" positionVCF="201704570" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="202569294" stop="202569294" display_start="202569294" display_stop="202569294" variantLength="1" positionVCF="202569293" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
      </Location>
      <OtherNameList>
        <Name>c.4721delT(4844delT)</Name>
      </OtherNameList>
      <ProteinChange>V1574fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.202569294del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.202569294del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.201704571del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.201704571del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008775.1" sequenceAccession="NG_008775" sequenceVersion="1" change="g.81602del">
            <Expression>NG_008775.1:g.81602del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020919.4" sequenceAccession="NM_020919" sequenceVersion="4" change="c.4721del" MANESelect="true">
            <Expression>NM_020919.4:c.4721del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_065970.2" sequenceAccession="NP_065970" sequenceVersion="2" change="p.Val1574fs">
            <Expression>NP_065970.2:p.Val1574fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_654" sequenceAccession="LRG_654">
            <Expression>LRG_654:g.81602del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_654t1" sequenceAccession="LRG_654t1">
            <Expression>LRG_654t1:c.4721del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_654p1" sequenceAccession="LRG_654p1" change="p.Val1574fs">
            <Expression>LRG_654p1:p.Val1574fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA340247" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="606352.0009" DB="OMIM" />
        <XRef Type="rs" ID="386134188" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_020919.4(ALS2):c.4721del (p.Val1574fs) AND Infantile-onset ascending hereditary spastic paralysis" Accession="RCV000004662" Version="14">
        <ClassifiedConditionList TraitSetID="1214">
          <ClassifiedCondition DB="MedGen" ID="C2931441">Infantile-onset ascending hereditary spastic paralysis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2011-02-10" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2011-02-10" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2013-05-03" MostRecentSubmission="2020-02-24">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12509863</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301421</ID>
          <ID Source="BookShelf">NBK1243</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1214" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4157" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Spastic paralysis, infantile onset ascending</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Autosomal Recessive Juvenile Amyotrophic Lateral Sclerosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Infantile-onset ascending hereditary spastic paralysis</ElementValue>
                <XRef ID="Infantile-onset+ascending+hereditary+spastic+paralysis/3819" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011797" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">IAHSP</ElementValue>
                <XRef Type="MIM" ID="607225" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">ALS2-related disorder involves retrograde degeneration of the upper motor neurons of the pyramidal tracts and comprises a clinical continuum of the following three phenotypes: Infantile ascending hereditary spastic paraplegia (IAHSP), characterized by onset of spasticity with increased reflexes and sustained clonus of the lower limbs within the first two years of life, progressive weakness and spasticity of the upper limbs by age seven to eight years, and wheelchair dependence in the second decade with progression toward severe spastic tetraparesis and a pseudobulbar syndrome caused by progressive cranial nerve involvement. Juvenile primary lateral sclerosis (JPLS), characterized by upper motor neuron findings of pseudobulbar palsy and spastic quadriplegia without dementia or cerebellar, extrapyramidal, or sensory signs. Juvenile amyotrophic lateral sclerosis (JALS or ALS2), characterized by onset between ages three and 20 years. All affected individuals show a spastic pseudobulbar syndrome (spasticity of speech and swallowing) together with spastic paraplegia. Some individuals are bedridden by age 12 to 50 years.</Attribute>
                <XRef ID="NBK1243" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000528540" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000514976" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000249543" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4914" />
                <XRef ID="4914" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301421</ID>
                <ID Source="BookShelf">NBK1243</ID>
              </Citation>
              <XRef ID="293168" DB="Orphanet" />
              <XRef ID="C2931441" DB="MedGen" />
              <XRef ID="MONDO:0011797" DB="MONDO" />
              <XRef Type="MIM" ID="607225" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="24836" SubmissionDate="2020-02-21" DateLastUpdated="2020-02-24" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="606352.0009_SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING" title="ALS2, 1-BP DEL, 4844T_SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING" />
        <ClinVarAccession Accession="SCV000024836" DateUpdated="2020-02-24" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a large consanguineous Pakistani family with infantile-onset complicated spastic paraparesis (IAHSP; 607225), Gros-Louis et al. (2003) identified a 1-bp deletion (4844delT) in exon 32 of the ALS2 gene. The proband presented with gait disturbance and hyperreflexia at 18 months and was anarthric and wheelchair-bound by age 12 years. Family history indicated that the disease slowly progressed to tetraplegia and death by the fourth decade, with relatively preserved intellect. The mutation cosegregated with the disease in the family and was absent in 155 control individuals.</Attribute>
              <Citation>
                <ID Source="PubMed">12509863</ID>
              </Citation>
              <XRef DB="OMIM" ID="607225" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALS2" />
          </GeneList>
          <Name>ALS2, 1-BP DEL, 4844T</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 4844T</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606352.0009" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="99687" SubmissionDate="2013-04-30" DateLastUpdated="2013-05-03" DateCreated="2013-05-03">
        <ClinVarSubmissionID localKey="c.4721delT(4844delT)_NBK1243" title="c.4721delT(4844delT) and ALS2-Related Disorders" />
        <ClinVarAccession Accession="SCV000058635" DateUpdated="2013-05-03" DateCreated="2013-05-03" Type="SCV" Version="1" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-02-10">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>pathologic</GermlineClassification>
          <Comment>Converted during submission to Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>not provided</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <Purpose>Assert pathogenicity</Purpose>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="nucleotide change">c.4721delT(4844delT)</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ALS2-Related Disorders</ElementValue>
            </Name>
            <XRef DB="GeneReviews" ID="NBK1243" />
            <XRef DB="OMIM" ID="607225" Type="MIM" />
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="24836" TraitType="Disease" MappingType="Name" MappingValue="SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING" MappingRef="Preferred">
        <MedGen CUI="C2931441" Name="Infantile-onset ascending hereditary spastic paralysis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="99687" TraitType="Disease" MappingType="Name" MappingValue="ALS2-Related Disorders" MappingRef="Preferred">
        <MedGen CUI="CN169291" Name="ALS2-related disorder" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

